Stoke Therapeutics, Inc.
STOK
DELAYED 1 MONTH
16 insider filings · Latest: Jun 3, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 3 9:33 PM | Barry TichoCHIEF MEDICAL OFFICER | Sale | 1,795 | $30.58 | $54.9K | 34,826(D) | View → |
| May 1, 2026 | May 5 8:18 PM | Barry TichoCHIEF MEDICAL OFFICER | Sale | 2,243 | $32.79 | $73.5K | 36,621(D) | View → |
| Mar 10, 2026 | Mar 12 8:57 PM | Arthur TzianabosDirector, Interim Executive Chair | Sale | 4,355 | $40.00 | $174.2K | 31,339(D) | View → |
| Mar 10, 2026 | Mar 12 8:56 PM | Adrian R. KrainerDirector | Sale | 33,243 | $39.74 | $1.3M | 283,302(D) | View → |
| Mar 2, 2026 | Mar 4 9:28 PM | Adrian R. KrainerDirector | Sale | 7,229 | $39.66 | $286.7K | 316,545(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 5 8:33 PM | Arthur TzianabosDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:31 PM | Julie SmithDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:30 PM | LEVIN ARTHUR ADirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:29 PM | Adrian R. KrainerDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:27 PM | Edward M. Kaye MDDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:26 PM | Seth Loring HarrisonDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:24 PM | Jennifer BursteinDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Mar 15, 2026 | Mar 17 9:26 PM | Jason HoittChief Patient Officer | Option Exercise | 10,000 | — | 30,000(D) | View → |
| Mar 15, 2026 | Mar 17 9:25 PM | Barry TichoCHIEF MEDICAL OFFICER | Option Exercise | 33,850 | — | 32,250(D) | View → |
| Mar 15, 2026 | Mar 17 9:24 PM | Edward M. Kaye MDDirector | Option Exercise | 61,750 | — | 52,500(D) | View → |
| Mar 15, 2026 | Mar 17 9:23 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Option Exercise | 25,475 | — | 36,000(D) | View → |
| Mar 10, 2026 | Mar 12 8:57 PM | Arthur TzianabosDirector, Interim Executive Chair | Option Exercise | 3,955 | $8.33 | 118,696(D) | View → |